Skip to main content
JAMA Network logoLink to JAMA Network
. 2022 Nov 23;80(1):96. doi: 10.1001/jamapsychiatry.2022.3947

Error in Table 2 and Discussion

PMCID: PMC9685540  PMID: 36416847

The Original Investigation titled “Estimating the Prevalence of Substance Use Disorders in the US Using the Benchmark Multiplier Method,”1 published on September 21, 2022, was corrected to fix the data in Table 2 and the 12-month prevalence estimates for cannabis use and alcohol use disorder from the National Survey on Drug Use and Health from 2019 to 2020. Table 2 was updated because the data from eTable 6 were inadvertently pasted into it by mistake. The prevalence of cannabis use had been reported as increasing from 5.3% in 2019 to 10.2% in 2020 and has been corrected to 1.8% to 5.1%, and the prevalence of alcohol use disorder had been reported as increasing from 4.3% in 2019 to 10.2% in 2020 and has been corrected to 5.3%to 10.2%. The corrections do not change the results substantively, the interpretation of the results, or the article’s conclusions. This article was corrected online.

Reference

  • 1.Mojtabai R. Estimating the prevalence of substance use disorders in the US using the benchmark multiplier method. JAMA Psychiatry. Published online September 21, 2022. doi: 10.1001/jamapsychiatry.2022.2756 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from JAMA Psychiatry are provided here courtesy of American Medical Association

RESOURCES